Aaron Brinkworth
Fortuna: 12 692 $ al 30/09/2026
Fortuna: 12 692 $ al 30/09/2026
Mr. Aaron Brinkworth is an Independent Non-Executive Director at Proteomics International Laboratories Ltd. and a Chairman at Resonance Health Ltd. He is on the Board of Directors at Proteomics International Laboratories Ltd. and Lixa Pty Ltd. Mr. Brinkworth was previously employed as an Executive Director-Global Patient Solutions by Gilead Sciences, Inc. He received his undergraduate degree from the University of Edith Cowan.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/06/2025 | 135.135 ( 0,08 % ) | 12 692 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| RESONANCE HEALTH LIMITED | Presidente | 13/11/2025 |
| PROTEOMICS INTERNATIONAL LABORATORIES LTD | Director/Miembro de la Junta | 08/11/2024 |
Lixa Pty Ltd.
Lixa Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops antimicrobial resistance | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/08/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Resonance Health Ltd.
Resonance Health Ltd. Medical/Nursing ServicesHealth Services Operates as a healthcare company, which involves in the development and commercialization of technologies & services for radiological images | Health Services |
University of Edith Cowan
University of Edith Cowan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd. Medical/Nursing ServicesHealth Services Provides biological research and drug discovery services | Health Services |
Lixa Pty Ltd.
Lixa Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops antimicrobial resistance | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.